Member of the Board - Shareholder @ IMCYSE (November 2012 - January 2022)
CEO @ (December 2017 - January 2019)
Chairman and reference shareholder @ (January 2012 - December 2017)
General Manager @ Uteron Pharma (January 2013 - August 2015)
Board member and CO-CEO @ Uteron Pharma (January 2009 - January 2013)
CEO @ UTERON OPERATIONS (December 2009 - January 2013)
CEO @ (September 2006 - November 2008)
CFO @ (January 2000 - January 2006)
BBL- ING rep office NY @ BBL - ING (September 1999 - September 2000)
Stijn van Rompay Education
University of Antwerp
Master (Economics)
1996-2000
Stijn van Rompay Skills
Pharmaceuticals
Healthcare
Pharmaceutical Industry
Mergers
Cross-functional Team Leadership
Lifesciences
Venture Capital
Pharmaceutical Sales
Private Equity
Business Planning
Medical Devices
Sales Effectiveness
Regulatory Affairs
Due Diligence
Strategic Planning
Corporate Finance
New Business Development
Corporate Development
Biotechnology
Business Strategy
M&A experience
Mergers & Acquisitions
International Business
Pharmaceutics
Strategy
Technology Transfer
Market Analysis
Management Consulting
Commercialization
Market Access
Product Launch
Product Development
Biopharmaceuticals
Life Sciences
Business Development
Financial Analysis
Research
Management
Cross Functional Team Leadership
Mergers and Acquisitions
Finance
Stijn van Rompay Summary
Stijn van Rompay, based in Keerbergen, BE, is currently a CEO and reference shareholder at Hyloris Pharmaceuticals. Stijn van Rompay brings experience from previous roles at PE group, EXO Biologics, IMCYSE and ALTER PHARMA. Stijn van Rompay holds a 1996 - 2000 Master in Economics @ University of Antwerp. With a robust skill set that includes Pharmaceuticals, Healthcare, Pharmaceutical Industry, Mergers, Cross-functional Team Leadership and more. Stijn van Rompay has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Stijn van Rompay?
Find contact details for 700 million professionals.